Literature DB >> 28416194

Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.

Alessia Angelin1, Luis Gil-de-Gómez2, Satinder Dahiya3, Jing Jiao4, Lili Guo2, Matthew H Levine5, Zhonglin Wang5, William J Quinn6, Piotr K Kopinski7, Liqing Wang3, Tatiana Akimova3, Yujie Liu3, Tricia R Bhatti3, Rongxiang Han3, Benjamin L Laskin4, Joseph A Baur6, Ian A Blair2, Douglas C Wallace8, Wayne W Hancock3, Ulf H Beier9.   

Abstract

Immune cells function in diverse metabolic environments. Tissues with low glucose and high lactate concentrations, such as the intestinal tract or ischemic tissues, frequently require immune responses to be more pro-tolerant, avoiding unwanted reactions against self-antigens or commensal bacteria. T-regulatory cells (Tregs) maintain peripheral tolerance, but how Tregs function in low-glucose, lactate-rich environments is unknown. We report that the Treg transcription factor Foxp3 reprograms T cell metabolism by suppressing Myc and glycolysis, enhancing oxidative phosphorylation, and increasing nicotinamide adenine dinucleotide oxidation. These adaptations allow Tregs a metabolic advantage in low-glucose, lactate-rich environments; they resist lactate-mediated suppression of T cell function and proliferation. This metabolic phenotype may explain how Tregs promote peripheral immune tolerance during tissue injury but also how cancer cells evade immune destruction in the tumor microenvironment. Understanding Treg metabolism may therefore lead to novel approaches for selective immune modulation in cancer and autoimmune diseases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cell metabolism; immune regulation; immunometabolism

Mesh:

Substances:

Year:  2017        PMID: 28416194      PMCID: PMC5462872          DOI: 10.1016/j.cmet.2016.12.018

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  62 in total

1.  Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.

Authors:  Ran Tao; Liqing Wang; Rongxiang Han; Tao Wang; Qunrui Ye; Takasu Honjo; Theresa L Murphy; Kenneth M Murphy; Wayne W Hancock
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

2.  Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.

Authors:  Edwin F de Zoeten; Liqing Wang; Hong Sai; Wolfgang H Dillmann; Wayne W Hancock
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

Review 3.  Regulatory T cells in cancer immunotherapy.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2014-01-14       Impact factor: 7.486

4.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

5.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 6.  Regulatory T cells in tumor immunity.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

Review 7.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

8.  Standardization, Evaluation, and Area-Under-Curve Analysis of Human and Murine Treg Suppressive Function.

Authors:  Tatiana Akimova; Matthew H Levine; Ulf H Beier; Wayne W Hancock
Journal:  Methods Mol Biol       Date:  2016

9.  Helios expression is a marker of T cell activation and proliferation.

Authors:  Tatiana Akimova; Ulf H Beier; Liqing Wang; Matthew H Levine; Wayne W Hancock
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

10.  Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells.

Authors:  Julia Billiard; Jennifer B Dennison; Jacques Briand; Roland S Annan; Deping Chai; Mariela Colón; Christopher S Dodson; Seth A Gilbert; Joel Greshock; Junping Jing; Hong Lu; Jeanelle E McSurdy-Freed; Lisa A Orband-Miller; Gordon B Mills; Chad J Quinn; Jessica L Schneck; Gilbert F Scott; Anthony N Shaw; Gregory M Waitt; Richard F Wooster; Kevin J Duffy
Journal:  Cancer Metab       Date:  2013-09-06
View more
  292 in total

1.  Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation.

Authors:  Fengqi Hao; Miaomiao Tian; Xinbo Zhang; Xin Jin; Ying Jiang; Xue Sun; Yang Wang; Pinghui Peng; Jia Liu; Chaoyi Xia; Yunpeng Feng; Min Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

Review 2.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

3.  Immunometabolism: From basic mechanisms to translation.

Authors:  Liza Makowski; Mehdi Chaib; Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

Review 4.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 5.  Metabolic Barriers to T Cell Function in Tumors.

Authors:  Ayaka Sugiura; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

6.  CD8+ T Cells and NK Cells: Parallel and Complementary Soldiers of Immunotherapy.

Authors:  Jillian Rosenberg; Jun Huang
Journal:  Curr Opin Chem Eng       Date:  2017-12-14       Impact factor: 5.163

7.  Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity.

Authors:  Themis Alissafi; Lydia Kalafati; Maria Lazari; Anastasia Filia; Ismini Kloukina; Maria Manifava; Jong-Hyung Lim; Vasileia Ismini Alexaki; Nicholas T Ktistakis; Triantafyllos Doskas; George A Garinis; Triantafyllos Chavakis; Dimitrios T Boumpas; Panayotis Verginis
Journal:  Cell Metab       Date:  2020-07-31       Impact factor: 27.287

Review 8.  Biochemical Underpinnings of Immune Cell Metabolic Phenotypes.

Authors:  Benjamin A Olenchock; Jeffrey C Rathmell; Matthew G Vander Heiden
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 9.  Metabolic reprogramming and apoptosis sensitivity: Defining the contours of a T cell response.

Authors:  Kelsey Voss; Sasha E Larsen; Andrew L Snow
Journal:  Cancer Lett       Date:  2017-09-01       Impact factor: 8.679

Review 10.  Lactate modulation of immune responses in inflammatory versus tumour microenvironments.

Authors:  Michelangelo Certo; Chin-Hsien Tsai; Valentina Pucino; Ping-Chih Ho; Claudio Mauro
Journal:  Nat Rev Immunol       Date:  2020-08-24       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.